Johnson & Johnson Vaccine: Effectiveness Against Brazil Variant and Key Insights
Johnson & Johnson’s vaccine is effective against the Brazil variant (P.2) and other SARS-CoV-2 variants. Clinical trials show it offers significant protection against various strains, including the B1.351 variant from South Africa, confirming its overall efficacy against these variants. Key insights reveal that the Johnson & Johnson vaccine provides long-lasting immunity. Studies indicate that protective … Read more